15 %15% of young women receiving PrEP reported previously using HIV self-testing.
KenyaVIH/sidaobservé February to November 2019publié 2020Journal of the International AIDS SocietyPubMeddocument de 7 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
2 235 evidences · page 78 / 90
15 %15% of young women receiving PrEP reported previously using HIV self-testing.
KenyaVIH/sidaobservé February to November 2019publié 2020Journal of the International AIDS SocietyPubMeddocument de 7 observations
300 dilution_ratioTwo superinfected individuals were able to neutralize variants from four different HIV-1 subtypes at plasma dilutions greater than 1:300.
KenyaVIH/sidapublié 2012PLoS pathogenseurope_pmcdocument de 3 observationsDOI 10.1371/journal.ppat.1002611
29,37 %L'incidence de la neuropathie chez les personnes vivant avec le VIH au Kenya était de 29,37 % en 2016.
KenyaVIH/sidaobservé 2016HAL · Unilimdocument de 747 observations
29,6 %The prevalence of intimate partner violence in the past year among women with HIV in serodifferent relationships in Nairobi, Kenya was 29.6%.
KenyaVIH/sidapublié 2022PloS onePubMeddocument de 8 observations
7,2 %At 12 months postpartum, 96 women (7.2%) were lost-to-follow-up (LTFU).
KenyaVIH/sidapublié 2022Journal of the International AIDS Societyeurope_pmcdocument de 5 observations
At 12 months, there were no significant differences in mean CD4 count or viral load suppression between the intervention and control groups.
KenyaVIH/sidaobservé 12 monthspublié 2021Journal of acquired immune deficiency syndromes (1999)PubMed
0,48 ratioIn adjusted analyses, HIV prevalence among female sex workers accessing SWOP clinics in Nairobi in 2014 was associated with an adjusted prevalence ratio of 0.48 compared with 2008.
KenyaVIH/sidaobservé 2014publié 2021AIDS (London, England)PubMeddocument de 13 observations
21 casesMajor drug resistance mutations were detected in samples from 21 (14.6%) of 144 participants.
KenyaVIH/sidapublié 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 6 observations
2,3 %Fingerprint technology had a failure to enroll rate of 2.3% for unique patient matching and identification in an HIV care and treatment facility in Western Kenya.
KenyaVIH/sidapublié 2021Journal of medical Internet researchPubMeddocument de 11 observations
68 %By 2018, the estimated percentage of adolescent girls and young women who would know their HIV status was 68% if none were DREAMS invitees in Gem, western Kenya.
KenyaVIH/sidaobservé 2018publié 2022AIDS (London, England)PubMeddocument de 11 observations
21 percentage_pointsStandardized patient actor training resulted in an adjusted mean difference of 21.0 percentage points in guideline adherence score for preexposure prophylaxis (PrEP) care between intervention and control sites.
KenyaVIH/sidapublié 2024AIDS (London, England)PubMeddocument de 9 observations
16,3 %In the Standard APS arm, 16.3% (232/1422) of partners tested were newly diagnosed with HIV.
KenyaVIH/sidaobservé 2021publié 2024Journal of the International AIDS SocietyPubMeddocument de 15 observations
2,4 odds_ratioA unit increase in V3 loop's net-charge increased the odds of a virus being CXCR4-tropic by 2.4 times.
KenyaVIH/sidapublié 2022MedicinePubMeddocument de 6 observations
80 %Among people with HIV and blood pressure ≥160/100 mmHg who enrolled in the intervention (n = 120), 80% were retained in care at 1 year.
Kenyahypertension artérielle · VIH/sidapublié 2025Journal of the International AIDS SocietyPubMeddocument de 11 observations
12,6 %At baseline, HIV prevalence was 12.6% in intervention communities.
KenyaVIH/sidapublié 2020AIDS (London, England)PubMeddocument de 8 observations
7,2 %After 6 months on antiretroviral therapy, median CD4% increased by 7.2% (IQR 2.0–11.6%) among children with HIV.
KenyaVIH/sidapublié 2024AIDS (London, England)PubMeddocument de 5 observations
215 individualsA total of 215 HIV-negative and 108 HIV-positive men aged 18–35 years (median 26, IQR 23–30) were enrolled in the study.
KenyaVIH/sidapublié 2013PloS oneeurope_pmcdocument de 6 observations
31 %Performance monitoring explained 31% of outreach quality variation.
KenyaVIH/sidapublié 2025PloS onePubMeddocument de 8 observations
0,7 RRHaving higher adherence skills was associated with a relative risk of 0.70 for virologic non-suppression.
KenyaVIH/sidapublié 2021PloS onePubMeddocument de 6 observations
45 %45% of the adolescents and young adults living with HIV reported that disclosure positively influenced their clinic attendance.
KenyaVIH/sidaobservé 2019publié 2023Frontiers in public healthPubMeddocument de 18 observations
2,3 prevalence_ratioThe prevalence ratio for internalized stigma associated with self-disclosure was 2.3 (95% CI: 1.1–4.6).
KenyaVIH/sidapublié 2021AIDS and behaviorPubMeddocument de 13 observations
-0,8 percentage_pointsThe difference in virological suppression at week 48 between long-acting and oral therapy groups was -0.8 percentage points.
KenyaVIH/sidapublié 2024The Lancet. Infectious diseasesPubMeddocument de 10 observations
10 %The proportion of proximal tubular renal dysfunction (PTRD) was 10.0% in the TDF group compared to 3.1% in the TDF-sparing group.
KenyaVIH/sidapublié 2022PloS onePubMeddocument de 8 observations
87,2 %Ever testing for HIV among respondents increased from 87.2% to 95.6% (p < 0.04).
KenyaVIH/sidapublié 2022Journal of the International AIDS SocietyPubMeddocument de 10 observations
8 yearsMedian duration of antiretroviral therapy for PLHIV was 8 years.
KenyaVIH/sidapublié 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 8 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.